Stocks and InvestingStocks and Investing
Mon, February 27, 2023
Sun, February 26, 2023
Sat, February 25, 2023
Fri, February 24, 2023

Raghuram Selvaraju Reiterated (ACRS) at Strong Buy and Held Target at $50 on, Feb 24th, 2023


Published on 2024-10-28 01:54:02 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy and Held Target at $50 on, Feb 24th, 2023.

Raghuram has made no other calls on ACRS in the last 4 months.



There are 3 other peers that have a rating on ACRS. Out of the 3 peers that are also analyzing ACRS, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Raghuram


  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $38 on, Tuesday, February 7th, 2023
  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $29 on, Wednesday, December 14th, 2022
  • Corinne Jenkins of "Goldman Sachs" Initiated at Strong Buy and Held Target at $25 on, Thursday, December 1st, 2022